Ann Brazeau, CEO, MPN Advocacy and Education International, and Dr. Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, attended an “open” meeting held by the US Department of Veterans Affairs with the National Academy of Sciences’ (NAS) Committee on Agent Orange and Health. The meeting, held in Washington, DC on March 1st, addressed myeloproliferative neoplasms for the first time ever. They are now being considered for further studies. Both Ann Brazeau and Dr. Rampal presented arguments to the committee regarding compensation and benefits to all veterans with an MPN, and related the scientific examination required to finally test the link between Agent Orange/Dioxin and myelofproliferative neoplasms.
A new committee has been established by the National Academy of Sciences (NAS) that will conduct a review and an update of scientific evidence regarding statistical associations between diseases and exposure to Dioxin and other chemical compounds used in Vietnam.
Dr. Rampal will begin his study in the near future. MPN Advocacy & Education International will be sending a questionnaire to all veterans affected by MPNs to begin collecting needed data to defend our case. In the meantime, we are completing a package that will help assist veterans with their claims.